Holen Sie sich die Stockscreener-App
1.22
1.67%
0.02
Schlusskurs vom Vortag:
$1.20
Offen:
$1.22
24-Stunden-Volumen:
127.12K
Relative Volume:
0.26
Marktkapitalisierung:
$56.99M
Einnahmen:
$13.18M
Nettoeinkommen (Verlust:
$-9.65M
KGV:
-6.4076
EPS:
-0.1904
Netto-Cashflow:
$-8.58M
1W Leistung:
+5.17%
1M Leistung:
-2.40%
6M Leistung:
-31.07%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.20
$1.31
1-Wochen-Bereich:
$1.12
$1.31
52-Wochen-Spanne:
$1.015
$2.99
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Firmenname
Mindwalk Holdings Corp
Sektor
Branche
Telefon
-
Adresse
-
Compare HYFT vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HYFT
Mindwalk Holdings Corp
|
1.22 | 56.05M | 13.18M | -9.65M | -8.58M | -0.1904 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-12-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-10-25 | Eingeleitet | The Benchmark Company | Buy |
Mindwalk Holdings Corp Aktie (HYFT) Neueste Nachrichten
Purchase/sale of business (net) of MindWalk Holdings Corp. – NASDAQ:HYFT - TradingView
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) Q3 2026 earnings call transcript - MSN
MindWalk Holdings Discloses March Insider Share Purchases in Voluntary U.S. Filing - TipRanks
MindWalk (NASDAQ: IPA) insiders add 60,000 shares in March 2026 buys - Stock Titan
Mindwalk Holdings: Zusammenarbeit mit Pfizer, Roche, Merck, Bayer…?! - Wallstreet Online
Mindwalk Holdings: Mit 19 der größten 20 Big-Pharma-Player „im Bett“ - Wallstreet Online
Top MindWalk (HYFT) Competitors 2026 - MarketBeat
Benchmark reiterates Speculative Buy on MindWalk Holdings stock By Investing.com - Investing.com Canada
Benchmark reiterates Speculative Buy on MindWalk Holdings stock - Investing.com
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2026 Earnings Call Transcript - Insider Monkey
H.C. Wainwright reiterates Buy on MindWalk stock on SaaS deal - Investing.com Nigeria
H.C. Wainwright reiterates Buy on MindWalk stock on SaaS deal By Investing.com - Investing.com India
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts - GuruFocus
MindWalk Holdings Corp. (HYFT) reports Q3 loss, lags revenue estimates - MSN
MindWalk Holdings Corp. 2026 Q3ResultsEarnings Call Presentation (NASDAQ:HYFT) 2026-03-12 - Seeking Alpha
MindWalk Holdings Corp. Q3 2026 Earnings Call Summary - Yahoo Finance
MindWalk (HYFT) Q3 2026 Earnings Call Transcript - The Globe and Mail
HYFT: Q3 revenue up 52% YoY, recurring LensAI contract signed, and pipeline programs advanced - TradingView
MindWalk Holdings Corp. (HYFT) Posts Third Quarter Loss, Falls Short of Revenue Expectations - Bitget
HYFT: Q3 FY 2026 revenue rose 52% YoY, with first enterprise contract and $14.2M cash on hand - TradingView
Q3 2026 MindWalk Holdings Corp Earnings Call Transcript - GuruFocus
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
MindWalk Holdings Corp reports results for the quarter ended January 31Earnings Summary - TradingView
MindWalk Holdings Files Q3 2026 MD&A and Interim Financials - TipRanks
HYFT: Q3 revenue up 52% to $4.2M, with recurring contracts and pipeline progress boosting outlook - TradingView
MindWalk Holdings (NASDAQ: IPA) grows revenue 45% and boosts margins amid AI pivot - Stock Titan
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results - The Joplin Globe
MindWalk Holdings Corp. (Nasdaq: HYFT) posts 52% Q3 revenue growth - Stock Titan
MindWalk Holdings emphasizes AI-driven strategy in latest financial release - MSN
MindWalk Holdings Corp PE Ratio (TTM) & PE Ratio (TTM) ChartsHYFT - GuruFocus
MindWalk launches nanobody discovery platform for bispecifics - Investing.com Nigeria
MindWalk Holdings Corp expected to post a loss of 5 cents a shareEarnings Preview - TradingView
MindWalk launches nanobody discovery platform for bispecifics By Investing.com - Investing.com Australia
MindWalk Announces B Cell Llama(TM), a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - irw-press.com
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - The National Law Review
MindWalk (HYFT) Introduces B Cell Llama for Enhanced Antibody Di - GuruFocus
MindWalk Unveils B Cell Llama Nanobody Platform Backed by Peer-Reviewed Study - TipRanks
New MindWalk (NASDAQ: HYFT) B Cell Llama platform targets bispecific and cell therapies - Stock Titan
HYFT Forecast, Price Target & Analyst Ratings | MINDWALK HOLDINGS CORP (NASDAQ:HYFT) - ChartMill
HYFT SEC FilingsMindWalk Holdings Corp 10-K, 10-Q, 8-K Forms - Stock Titan
MindWalk Holdings to Report Q3 2026 Earnings - National Today
MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - 01net
MindWalk Sets March 12 Date to Report Q3 2026 Results and Host Earnings Webcast - TipRanks
MindWalk (NASDAQ: IPA) sets March 12 call on Q3 FY 2026 results - Stock Titan
HYFT Technical Analysis & ETF Price Forecast - Intellectia AI
Zacks Research Upgrades MindWalk (NASDAQ:HYFT) to Hold - MarketBeat
Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire
MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks
Finanzdaten der Mindwalk Holdings Corp-Aktie (HYFT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):